Understand the source comparison
VIP Stack Comparison: Efficacy and Compatibility
VIP + BPC-157 Moderate (cAMP pathway) 4 hours minimum High. Pathways reinforce Gut-brain axis inflammation, autoimmune protocols Synergistic if timed correctly; BPC-157's tissue repair complements VIP's immune modulation VIP + Thymosin Beta-4 Low (independent
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- VIP + BPC-157
- Moderate (cAMP pathway)
- 4 hours minimum
- High. Pathways reinforce
- Gut-brain axis inflammation, autoimmune protocols
- Synergistic if timed correctly; BPC-157's tissue repair complements VIP's immune modulation
- VIP + Thymosin Beta-4
- Low (independent pathways)
- 2 hours acceptable
- Very High. No competition
- Immune reconstitution, chronic inflammation
- Ideal combination; thymosin's actin mechanism is orthogonal to VIP's receptor signalling
- VIP + MK-677 / Growth Secretagogues
- Low (different receptor families)
- 12+ hours (opposite ends of day)
- High. Preserve circadian dynamics
- Age-related decline, body composition studies
- Timing is critical; VIP morning, GH pulse pre-sleep maintains natural rhythm
- VIP + Cerebrolysin / Dihexa
- Minimal (neurotrophic vs anti-inflammatory)
- 4 hours recommended
- Very High. Complementary mechanisms
- Neurodegenerative research, cognitive enhancement
- VIP reduces neuroinflammation while neurotrophics drive BDNF/NGF. Additive benefit
- VIP + Survodutide / Tesofensine
- None (metabolic vs immune)
- No spacing required
- Very High. Independent pathways
- Metabolic syndrome, obesity research
- Can be co-administered; GLP-1 and VIP operate on entirely separate receptor systems